News

Information to the Marketing Authorisation Holder - Nasonex - 28.1.2015

Referral Art. 30, EMEA/H/A-30/1375 regarding  Nasonex and associated names was finalised 20 January 2015.

Information to the Marketing Authorisation Holder – Colistimethate Alvogen - 8.1.2015

Referral Art. 31, EMEA/H/A-31/1383 regarding Colistimethate Alvogen 1 milljón a.e. og 2 milljónir a.e. stungulyfs-/innrennslisstofn, lausn was finalised 17 December 2014.

Information to the Marketing Authorisation Holder – Docetaxel (with alcohol in formulation) - 30.12.2014

Referral Art. 107i, EMEA/H/C/PSUSA/1152/201311 regarding Docetaxel (with alcohol in formulation) was finalised 23 December 2014.

See all